Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Recent study has shown that LRRK2 G-domain cycles between monomeric and dimeric conformations upon binding to GTP or guanosine diphosphate, and that the Parkinson's disease (PD)-associated R1441C/G/H mutations impair the G-domain monomer-dimer dynamics and trap the G-domain in a constitutive monomeric conformation. 30592623

2019

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE In addition, VPA induced the improvement of PD-like motor and non-motor behavior in LRRK2 R1441G mice. 31495079

2019

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE LRRK2 mutations that cause PD including R1441C, Y1699C, and G2019S all increase LRRK2 phosphorylation of Rab7L1 four-fold over wild-type LRRK2 in cells, resulting in the phosphorylation of nearly one-third the available Rab7L1 protein in cells. 29177506

2018

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Furthermore, judged by the phenotypes presented, the LRRK2-R1441C knock-in line is a valid preclinical model for the prodromal phase of PD. 28576705

2017

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE The heterozygous R1441C mutation of leucine-rich repeat kinase 2 gene in a Chinese patient with Parkinson disease: A five-year follow-up and literatures review. 28131193

2017

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease. 27794539

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Mutations in Leucine-rich repeat kinase 2 NM_198578 (LRRK2 c.6055G > A (p.G2019S), LRRK2 c.4321C > G (p.R1441G)) and alpha-synuclein NM_000345 (SNCA c.209G > A (p.A53T)) genes causing Parkinson's disease (PD) are common in Mediterranean populations. 27613114

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE However, examination of clinical records revealed the p.R1441C carrier to have PD with dementia. 27521182

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE The most prevalent Parkinson's disease LRRK2 mutations are located in the kinase (G2019S) and GTPase (R1441C) encoding domains of LRRK2. 26744332

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. 27111571

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease. 26686514

2016

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease. 26192625

2015

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE A comprehensive interview conducted by sleep specialists, validated sleep scales and questionnaires, and video-polysomnography followed by multiple sleep latency test (MSLT) assessed sleep in 18 LRRK2-PD (17 carrying G2019S and one R1441G mutations), 17 NMC (11 G2019S, three R1441G, three R1441C), 14 non-manifesting non-carriers (NMNC) and 19 unrelated IPD. 26177462

2015

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE We examined cognition and psychiatric symptoms in 27 patients with LRRK2-PD (12 G2019S and 15 R1441G) and 27 iPD patients. 25840672

2015

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE In conclusion, these data clearly demonstrate that LRRK2 kinase activity is modulated by PKA-mediated binding of 14-3-3 to S1444 and suggest that 14-3-3 interaction with LRRK2 is hampered in R1441C/G/H-mediated PD pathogenesis. 24351927

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Furthermore, the PD-related LRRK2 R1441C missense mutation in the GTPase domain interfered with the interaction of LRRK2 with Sec16A and also affected ER-Golgi transport, while LRRK2 kinase activity was not required for these functions. 25201882

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Additionally, in samples from patients with the R1441G mutation and with idiopathic PD, we found a prominent cytoplasmic re-distribution of human antigen R, a protein that, among others, stabilizes COX-2 RNA. 24360742

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE The R1441C and G2019S mutations are not rare causes of PD in Campania, especially in the province of Naples and among the familial cases, where the overall mutation prevalence is 6.8%. 24496098

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE In conclusion, significant differences were not detected between R1441G-PD and i-PD in cognitive, depression and anxiety scales, or PD-MCI and PD-Dementia prevalence, and the cognitive profile was identical in the two groups. 25127457

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Cancer prevalence was not significantly higher in PD-G2019S carriers (20%) than in PD-R1441G carriers (14.3%), iPD (13.8%), or controls (12.5%). 24357540

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE This is the first report of familial PD because of the LRRK2 p.R1441G mutation in Asia. 24973808

2014

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE We studied 25 PD patients: 12 with the LRRK2 mutation (6 G2019S and 6 R1441G), and 13 with iPD. 23764467

2013

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE The parkinson's disease-associated LRRK2 mutation R1441G inhibits neuronal differentiation of neural stem cells. 23600457

2013

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Moreover, lipopolysaccharide (LPS)-activated microglial cells from mice overexpressing the Parkinson's disease-linked LRRK2(R1441G) mutation exhibit increased expression and secretion of proinflammatory cytokines compared with wild-type control microglia. 22342962

2012

dbSNP: rs33939927
rs33939927
0.100 GeneticVariation BEFREE Patients with Parkinson's disease were screened for R1441G and G2019S LRRK2 gene mutations and classified as LRRK2 mutation carriers or noncarriers. 21611983

2011